Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Nashville, TN
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Fort Worth, TX
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Buenos Aires,
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Buenos Aires,
Click here to add this to my saved trials
Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
LS1081, "A Pilot Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation or Intradermally for Patients With B-Cell Non-Hodgkin's Lymphoma"
Status: Enrolling
Updated:  3/21/2017
The Mayo Clinic
mi
from
Rochester, MN
Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
LS1081, "A Pilot Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation or Intradermally for Patients With B-Cell Non-Hodgkin's Lymphoma"
Status: Enrolling
Updated: 3/21/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
Phase I Trial of Sorafenib Maintenance Therapy for Patients With FLT3-ITD AML After Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
Phase I Trial of Sorafenib Maintenance Therapy for Patients With FLT3-ITD AML After Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
Phase I Trial of Sorafenib Maintenance Therapy for Patients With FLT3-ITD AML After Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
Phase I Trial of Sorafenib Maintenance Therapy for Patients With FLT3-ITD AML After Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Status: Enrolling
Updated:  3/28/2017
UPMC
mi
from
Pittsburgh, PA
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Status: Enrolling
Updated: 3/28/2017
UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed With Lobular Neoplasia of the Breast by Core Needle Biopsy
Status: Enrolling
Updated:  3/30/2017
Dana-Farber Cancer Center
mi
from
Boston, MA
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed With Lobular Neoplasia of the Breast by Core Needle Biopsy
Status: Enrolling
Updated: 3/30/2017
Dana-Farber Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed With Lobular Neoplasia of the Breast by Core Needle Biopsy
Status: Enrolling
Updated:  3/30/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed With Lobular Neoplasia of the Breast by Core Needle Biopsy
Status: Enrolling
Updated: 3/30/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
Status: Enrolling
Updated:  3/30/2017
Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center
mi
from
New York, NY
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
Status: Enrolling
Updated: 3/30/2017
Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
A Pilot Trial of Unrelated Umbilical Cord Blood Transplantation Augmented With Ex Vivo CytokinePrimed ALDHbr Umbilical Cord Blood Cells
Status: Enrolling
Updated:  4/3/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
A Pilot Trial of Unrelated Umbilical Cord Blood Transplantation Augmented With Ex Vivo CytokinePrimed ALDHbr Umbilical Cord Blood Cells
Status: Enrolling
Updated: 4/3/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Status: Enrolling
Updated:  4/3/2017
Child Development and Rehabilitation Center, Oregon Health & Science University
mi
from
Portland, OR
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Status: Enrolling
Updated: 4/3/2017
Child Development and Rehabilitation Center, Oregon Health & Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Status: Enrolling
Updated:  4/3/2017
O&O Alpan
mi
from
Fairfax, VA
Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Status: Enrolling
Updated: 4/3/2017
O&O Alpan
mi
from
Fairfax, VA
Click here to add this to my saved trials
Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration
Fentanyl-Propofol-EMLA or L.M.X4™ Technique for Bone Marrow Aspiration in Pediatric Patients - A Phase III Study
Status: Enrolling
Updated:  4/3/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration
Fentanyl-Propofol-EMLA or L.M.X4™ Technique for Bone Marrow Aspiration in Pediatric Patients - A Phase III Study
Status: Enrolling
Updated: 4/3/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
St. Joseph's Hospital - Resurgeons Orthopedics
mi
from
Atlanta, GA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
St. Joseph's Hospital - Resurgeons Orthopedics
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Arthritis & Joint Center - U. Mass. Memorial
mi
from
Worcester, MA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Arthritis & Joint Center - U. Mass. Memorial
mi
from
Worcester, MA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
PRESSD
mi
from
Southfield, MI
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
PRESSD
mi
from
Southfield, MI
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Montana Neuroscience Institute Foundation
mi
from
Missoula, MT
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Montana Neuroscience Institute Foundation
mi
from
Missoula, MT
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Syracuse Orthopedic Specialists
mi
from
Syracuse, NY
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Syracuse Orthopedic Specialists
mi
from
Syracuse, NY
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Neurosurgical Associates
mi
from
Nashville, TN
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Neurosurgical Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Brain & Spine of Texas
mi
from
Plano, TX
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Brain & Spine of Texas
mi
from
Plano, TX
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
UCSF
mi
from
San Francisco, CA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Carrollton Orthopedics
mi
from
Carrollton, GA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Carrollton Orthopedics
mi
from
Carrollton, GA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Bluegrass Orthopedics & Hand Care Research
mi
from
Lexington, KY
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bluegrass Orthopedics & Hand Care Research
mi
from
Lexington, KY
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Physicians Research Options Spine Center
mi
from
Las Vegas, NV
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Physicians Research Options Spine Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Buda Health Center
mi
from
Budapest,
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Buda Health Center
mi
from
Budapest,
Click here to add this to my saved trials
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated:  4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated: 4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  4/5/2017
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/5/2017
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  4/5/2017
Massachusetts General Hospital
mi
from
Boston, MA
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/5/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  4/5/2017
Mt. Sinai Medical Center
mi
from
New York, NY
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/5/2017
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  4/5/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/5/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  4/5/2017
Medical College of Wisconsin - Clinical Cancer Center
mi
from
Milwaukee, WI
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/5/2017
Medical College of Wisconsin - Clinical Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  4/5/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/5/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
UCLA Medical Center
mi
from
Los Angeles, CA
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
Indiana Blood and Marrow Transplant, LLC
mi
from
Indianapolis, IN
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
Indiana Blood and Marrow Transplant, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
University of Iowa
mi
from
Iowa City, IA
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
Ohio State University Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
mi
from
Columbus, OH
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
Ohio State University Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
University of Virginia Medical Center
mi
from
Charlottesville, VA
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
University of Virginia Medical Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated:  4/6/2017
VCU Medical Center
mi
from
Richmond, VA
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs
Status: Enrolling
Updated: 4/6/2017
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
Impact of Washed Transfusions in Adult Patients With Acute Myeloid or Lymphoid Leukemia
Status: Enrolling
Updated:  4/10/2017
Strong Memorial Hospital - University of Rochester Medical Center
mi
from
Rochester, NY
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
Impact of Washed Transfusions in Adult Patients With Acute Myeloid or Lymphoid Leukemia
Status: Enrolling
Updated: 4/10/2017
Strong Memorial Hospital - University of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated:  4/25/2017
The Stamford Hospital
mi
from
Stamford, CT
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated: 4/25/2017
The Stamford Hospital
mi
from
Stamford, CT
Click here to add this to my saved trials
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated:  4/25/2017
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated: 4/25/2017
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated:  4/25/2017
North Shore LIJ
mi
from
New Hyde Park, NY
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated: 4/25/2017
North Shore LIJ
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated:  4/25/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status: Enrolling
Updated: 4/25/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials